| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |